| 39.02 Delayed Data As of 4:00pm ET |  +0.36 / +0.93%Today’s Change | 34.38 Today|||52-Week Range 43.30 | +2.74% Year-to-Date |
| Zwj Investment Counsel Inc Buys Ingredion Inc, Outfront Media Inc, Citizens Financial... May 21 / GuruFocus NewsGURU - Paid Partner Content | 3 Top Diabetes Stocks to Watch in May May 15 / MotleyFool.com - Paid Partner Content |
| Rigel Initiates Enrollment in Pivotal Blood Disorder Study May 17 / Zacks.comZAK - Paid Partner Content | AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark May 11 / Zacks.com - Paid Partner Content |
| Previous close | 38.66 |
| Today’s open | 39.01 |
| Day’s range | 38.90 - 39.32 |
| Volume | 3,086,618 |
| Average volume (3 months) | 5,341,866 |
| Market cap | $103.1B |
| Earnings growth (last year) | -29.11% |
| Earnings growth (this year) | +1.57% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | -2.88% |
| P/E ratio | 41.1 |
| Price/Sales | 4.36 |
| Price/Book | 8.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.19 | +0.48% |
| SNYSanofi | +0.17 | +0.40% |
| NVONovo Nordisk | +0.21 | +0.43% |
| LLYEli Lilly and Co | -0.02 | -0.02% |
| Next reporting date | October 24, 2019 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $22.1B |
| Annual profit (last year) | $2.2B |
| Net profit margin | 9.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Pascal Soriot |
Executive VP-Operations & Information Technology Pam P. Cheng |
Corporate headquarters Cambridge, Cambridgeshire |
